{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:28:11Z","timestamp":1789835291402,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIA\/NIH","award":["U01 AG016976"],"award-info":[{"award-number":["U01 AG016976"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.neurobiolaging.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T22:48:22Z","timestamp":1509749302000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults"],"prefix":"10.1016","volume":"62","author":[{"given":"Willa D.","family":"Brenowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A.","family":"Kukull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1530\/EC-17-0028","article-title":"Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile","volume":"6","author":"Abreu","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.17219\/acem\/38555","article-title":"Evaluation of selected atherosclerosis risk factors in women with subclinical hypothyroidism treated with L-thyroxine","volume":"25","author":"Adamarczuk-Janczyszyn","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnagi.2015.00150","article-title":"Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis","volume":"7","author":"Akintola","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib4","first-page":"270","article-title":"The national Alzheimer's coordinating center (NACC) database: an Alzheimer disease database","volume":"18","author":"Beekly","year":"2004","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The national Alzheimer\u2019s coordinating center (NACC) database: the uniform data set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06131","article-title":"Thyroid hormone in health and disease","volume":"187","author":"Boelaert","year":"2005","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib9","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1210\/jc.2016-2255","article-title":"Thyroid function within the reference range and the risk of stroke: an individual participant data analysis","volume":"101","author":"Chaker","year":"2016","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib10","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2017-00410","article-title":"Defining optimal health range for thyroid function based on the risk of cardiovascular disease","volume":"102","author":"Chaker","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCULATIONAHA.115.020789","article-title":"Thyroid function and sudden cardiac death: a prospective population-based cohort study","volume":"134","author":"Chaker","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.0000000000003227","article-title":"Thyroid function and the risk of dementia: the Rotterdam Study","volume":"87","author":"Chaker","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/thy.2013.0058","article-title":"Hippocampal volume is decreased in adults with hypothyroidism","volume":"24","author":"Cooke","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neurobiolaging.2007.07.019","article-title":"Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study","volume":"30","author":"de Jong","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1871530317666170320105221","article-title":"Thyroid hormones, metabolic syndrome and its components","volume":"17","author":"Delitala","year":"2017","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000449055","article-title":"Associations between thyroid stimulating hormone levels and both severity and early outcome of patients with ischemic stroke","volume":"76","author":"Delpont","year":"2016","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-08-0140","article-title":"The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area","volume":"159","author":"Dorr","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1445-5994.2007.01367.x","article-title":"Prevalence of thyroid disease in an older Australian population","volume":"37","author":"Empson","year":"2007","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Frohlich","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871530311313010003","article-title":"Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies","volume":"13","author":"Gencer","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjmed.2015.11.027","article-title":"Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study","volume":"129","author":"Grossman","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib24","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2003-031089","article-title":"Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism","volume":"89","author":"Imaizumi","year":"2004","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11011-010-9208-8","article-title":"Structural and functional alterations in the hippocampus due to hypothyroidism","volume":"25","author":"Koromilas","year":"2010","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib27","series-title":"Endotext","article-title":"Ontogeny, anatomy, metabolism and physiology of the thyroid","author":"Maenhaut","year":"2000"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-2008-14109","article-title":"Thyroid function, Alzheimer's disease and postoperative cognitive dysfunction: a tale of dangerous liaisons?","volume":"14","author":"Mafrica","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3803\/EnM.2016.31.2.185","article-title":"Endocrine risk factors for cognitive impairment","volume":"31","author":"Moon","year":"2016","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jc.2013-3385","article-title":"Lower-but-normal serum TSH level is associated with the development or progression of cognitive impairment in elderly: Korean Longitudinal Study on Health and Aging (KLoSHA)","volume":"99","author":"Moon","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib57","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-016-1641-2","article-title":"Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging","volume":"132","author":"Nelson","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib34","first-page":"1875","article-title":"Association between male gender and cortical Lewy body pathology in large autopsy series","volume":"257","author":"Nelson","year":"2010","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jnen\/nlw033","article-title":"\u201cNew Old Pathologies\u201d: AD, PART, and cerebral age-related TDP-43 with sclerosis (CARTS)","volume":"75","author":"Nelson","year":"2016","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib36","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1210\/jc.2015-2046","article-title":"Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis","volume":"100","author":"Pasqualetti","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.numecd.2016.06.005","article-title":"Subclinical hypothyroidism is associated with higher carotid intima-media thickness in cross-sectional analysis of the Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"26","author":"Peixoto de Miranda","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13044-016-0034-x","article-title":"Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) - results from the feasibility randomised controlled trial","volume":"9","author":"Razvi","year":"2016","journal-title":"Thyroid Res."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib39","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2016-2129","article-title":"Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies","volume":"101","author":"Rieben","year":"2016","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib40","first-page":"337","article-title":"The neuropathology of congenital hypothyroidism","volume":"30","author":"Rosman","year":"1972","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2004-1083","article-title":"Increased cerebrospinal fluid levels of 3,3\u2032,5\u2032-triiodothyronine in patients with Alzheimer's disease","volume":"90","author":"Sampaolo","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib42","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archinte.1985.00360080056006","article-title":"The aging thyroid. Thyroid deficiency in the Framingham Study","volume":"145","author":"Sawin","year":"1985","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib43","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.STR.0000181772.78492.07","article-title":"Thyroid diseases and cerebrovascular disease","volume":"36","author":"Squizzato","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib45","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.168.14.1514","article-title":"Thyroid function and the risk of Alzheimer disease: the Framingham Study","volume":"168","author":"Tan","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-2009-0991","article-title":"Thyroid function and Alzheimer's disease","volume":"16","author":"Tan","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib47","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib48","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.WNL.0000128134.84230.9F","article-title":"Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease","volume":"62","author":"van Osch","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/eci.12423","article-title":"Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders","volume":"45","author":"van Tienhoven-Wind","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br. Med. Bull"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3413\/Nukmed-0852-16-10","article-title":"Prevalence of thyroid disorders in elderly people in Germany. A screening study in a country with endemic goitre","volume":"56","author":"Verburg","year":"2017","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2013.02.008","article-title":"Thyroid disorders in older adults","volume":"42","author":"Visser","year":"2013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib53","doi-asserted-by":"crossref","first-page":"31975","DOI":"10.1038\/srep31975","article-title":"Higher FT4 or TSH below the normal range are associated with increased risk of dementia: a meta-analysis of 11 studies","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib54","doi-asserted-by":"crossref","first-page":"E2230","DOI":"10.1210\/jc.2012-2108","article-title":"Higher free thyroxine levels predict increased incidence of dementia in older men: the health in men study","volume":"97","author":"Yeap","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/EJE-13-0306","article-title":"Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the health in men study","volume":"169","author":"Yeap","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2017.10.004_bib56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/cen.13383","article-title":"Subclinical hypothyroidism and risk of cerebral small vessel disease: a hospital-based observational study","volume":"87","author":"Zhang","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017303433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017303433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:26:23Z","timestamp":1759317983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458017303433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":56,"alternative-id":["S0197458017303433"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.10.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}